Komori
Asahi Intecc (7747) · InitiativeRestated

Collaboration between the U.S. R&D Base and Medical Institutions and External Partners

First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2019.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20192016: 120162017: 120172018: 120182019: 12019
Same theme, other companies
Collaboration Among Global R&D Sites and Joint DevelopmentA theme 38 companies write about · 0 as a headwind · 40 as a tailwind

13 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 38 companies compared. The sentences above are computed from all 38.
Full recordFilings, disclosures and news, newest first
  1. FY2019RestatedAnnual report

    「As part of the globalization of our R&D structure, at consolidated subsidiary ASAHI INTECC USA, INC., the base for direct sales in the United States, we have established an R&D structure capable of responding through the prototype stage, allowing us to directly incorporate the needs and evaluations of physicians, our end customers. We are also further expanding the R&D base of consolidated subsidiary ASAHI INTECC THAILAND CO., LTD. and will pursue improvements to existing products, including reviewing product specifications, more proactively.」

    The company continues to maintain a prototyping structure in the United States that reflects physicians’ needs, as well as its policy of expanding the R&D base in Thailand.
  2. FY2018RestatedAnnual report

    「At consolidated subsidiary ASAHI INTECC USA, INC., the base for direct sales in the United States, we have established an R&D structure capable of responding through the prototype stage, allowing us to directly incorporate the needs and evaluations of physicians, our end customers. We are also further expanding the R&D base of consolidated subsidiary ASAHI INTECC THAILAND CO., LTD. and will pursue improvements to existing products, including reviewing product specifications, more proactively.」

    The company continues to maintain a prototyping structure in the United States that reflects physicians’ needs, as well as its policy of expanding the R&D base in Thailand.
  3. FY2017RestatedAnnual report

    「In recent years, we have also strengthened our joint R&D system with leading physicians in each field who have extensive experience in clinical settings, leveraging the functions unique to our company, and have been developing products closely aligned with frontline medical needs.」

    The company continues to operate a global R&D system, including its U.S. R&D center, and conduct joint research with leading physicians.
  4. FY2016First statedAnnual report

    「In addition, we established a new R&D center at ASAHI INTECC USA, INC., our consolidated U.S. sales subsidiary, enabling us to produce prototypes and directly reflect the needs and evaluations of leading physicians working close to the front lines of medical care. By globalizing our R&D system, including prototype development, we will strengthen our capabilities in the field.」

    The company says it will establish an R&D center in the United States capable of producing prototypes and will also leverage joint research with leading physicians, technology partnerships and M&A.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Asahi Intecc yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Collaboration between the U.S. R&D Base and Medical Institutions and External Partners | ASAHI INTECC CO.,LTD. (7747) | Komori